Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.42

+1.50 (2.50%)

as of Sep 3, 2026, 8:00:00 pm Market Open.

1632 watching

Investor Insights

Sep 3, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial is navigating a complex landscape marked by both growth opportunities and challenges. While the company has reported a strong quarter and shows healthy growth, particularly in Asia and wealth management, concerns exist surrounding the newly imposed tax by the Chinese government on its products. The stock's valuation is drawing mixed reactions, with some experts noting it's currently overbought and trading above 2x book value. However, many analysts maintain a positive outlook, emphasizing its steady dividend yield and potential for long-term growth, particularly if macroeconomic conditions shift in its favor. Despite some recent underperformance compared to peers, strong fundamentals and a reliable business model position Manulife well for the future.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

WEAK BUY

Fair market value is only $42. Working very hard on the amalgamation of John Hancock so there is an unknown upside to come.

Wealthica Track your Stocks in your Watch List

TOP PICK

With the closure of the John Hancock deal, should earn $4.50 next year. Good entry point.

BUY

Life-insurance companies will benefit from rising interest rates through their big bond portfolios.

HOLD

Has had a tremendous run-up in the last 3/4 weeks. Likes the management and feels the John Hancock acquisition will work out very well. Expects the uptrend will continue.

BUY

Very well-managed. Likes their diversification. Yield is low, but stock could continue going up.

BUY

Has a lot going for it. Likes their far Eastern operations.

BUY

Good management. Expect they will take a lot of costs out of the business with the acquisition of John Hancock. Expecting good Asian growth.

BUY ON WEAKNESS

Should be about to put up some good growth in earnings with their John Hancock acquisition. Expect some selling pressure when Hancock shareholders get their Manulife shares and start selling them. That will be an opportunity to buy.

BUY

Likes the life insurance business, this company in particular. Strong management. Expect they will be ruthless in cutting costs in John Hancock.

BUY

The merger with John Hancock was good and at a reasonable price. This should create cost synergies. Has a strong global presence.

BUY

Likes the insurance industry. Very solid company and well managed. A good hold.

BUY

The Hancock acquisition will add a lot over the next couple of years. Likes their position in Asia as well.

PAST TOP PICK

(A top pick December 16/03. Up 11.5%.) They consolidate very well. Good earnings.

DON'T BUY

Has done a very good job in its acquisition strategy. Will have some digesting problems with the John Hancock acquisition.

BUY

Can go a lot higher now that they John Hancock shareholders have agreed to the sale. Asian assets are now profitable. A good long-term hold.

Showing 2,026 to 2,040 of 2,284 entries

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Jim Cramer - Mad Money

CNBC

Dan Rohinton

iA Global Asset Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)